Abvc Biopharma, Inc.
ABVC
Revenue
117.14k
▲115.94k▲9621.33%
3 Months ChangeAssets
14.63M
▲173.30k▲1.20%
3 Months ChangeLiabilities
6.81M
▼-168.04k▼-2.41%
3 Months ChangeFree Cash Flow
-3.09M
▼-3.05M▼-8393.75%
111 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-18
Form 8-K
ID: 0001213900-24-089013
2024-09-10
Form 8-K
ID: 0001213900-24-077361
2024-08-20
Form 8-K
ID: 0001213900-24-071145
2024-08-15
Form 8-K
ID: 0001213900-24-069338
2024-08-14
Form 10-Q
ID: 0001213900-24-068907
2024-07-23
Form 8-K
ID: 0001213900-24-063627
2024-07-12
Form 8-K
ID: 0001213900-24-061028
2024-05-24
Form 8-K
ID: 0001213900-24-046419
2024-05-23
Form 8-K
ID: 0001213900-24-046313
2024-05-17
Form 10-Q
ID: 0001213900-24-044731